IL112695A - Pharmaceutical compositions containing pyridazinone derivatives - Google Patents

Pharmaceutical compositions containing pyridazinone derivatives

Info

Publication number: IL112695A
Authority: IL; Israel
Prior art keywords: txa2; pct; mediated diseases; pharmaceutical compositions; compositions containing
Prior art date: 1994-02-22

Application number

IL11269595A

Other languages

English (en)

Other versions

IL112695A0 (en

Original Assignee

Green Cross Corp

Nissan Chemical Ind Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-02-22

Filing date

1995-02-19

Publication date

1999-04-11

1995-02-19 Application filed by Green Cross Corp, Nissan Chemical Ind Ltd filed Critical Green Cross Corp

1995-05-26 Publication of IL112695A0 publication Critical patent/IL112695A0/xx

1999-04-11 Publication of IL112695A publication Critical patent/IL112695A/xx

Links

AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical class OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
102000003960 Ligases Human genes 0.000 abstract 3
108090000364 Ligases Proteins 0.000 abstract 3
201000010099 disease Diseases 0.000 abstract 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
230000001404 mediated effect Effects 0.000 abstract 3
DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 abstract 3
239000003795 chemical substances by application Substances 0.000 abstract 2
239000003112 inhibitor Substances 0.000 abstract 2
238000011321 prophylaxis Methods 0.000 abstract 2
-1 pyridazinone compound Chemical class 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
238000011282 treatment Methods 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
230000000069 prophylactic effect Effects 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Confectionery (AREA)
Medicines Containing Plant Substances (AREA)
Pyridine Compounds (AREA)

IL11269595A 1994-02-22 1995-02-19 Pharmaceutical compositions containing pyridazinone derivatives IL112695A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2455694		1994-02-22

Publications (2)

Publication Number	Publication Date
IL112695A0 IL112695A0 (en)	1995-05-26
IL112695A true IL112695A (en)	1999-04-11

Family

ID=12141437

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11269595A IL112695A (en)	1994-02-22	1995-02-19	Pharmaceutical compositions containing pyridazinone derivatives

Country Status (16)

Country	Link
US (1)	US5798357A (fr)
EP (1)	EP0744950B1 (fr)
JP (1)	JP3858279B2 (fr)
KR (1)	KR100345187B1 (fr)
CN (1)	CN1084620C (fr)
AT (1)	ATE273708T1 (fr)
AU (1)	AU1718395A (fr)
CA (1)	CA2183234C (fr)
DE (1)	DE69533392T2 (fr)
DK (1)	DK0744950T3 (fr)
ES (1)	ES2222464T3 (fr)
FI (1)	FI116882B (fr)
IL (1)	IL112695A (fr)
NO (1)	NO311490B1 (fr)
WO (1)	WO1995022329A1 (fr)
ZA (1)	ZA951470B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW482675B (en) *	1997-01-31	2002-04-11	Green Cross Corp	Compositions for oral administration containing pyridazinone compounds technical field of the invention
WO1999011268A1 (fr)	1997-08-28	1999-03-11	Yoshitomi Pharmaceutical Industries, Ltd.	Agents promoteurs et agents potentialisateurs de la neovascularisation
US6143113A (en)	1998-03-02	2000-11-07	Le Groupe Recherche I.D. Inc.	Repulpable corrugated boxboard
RU2229297C2 (ru)	1998-09-01	2004-05-27	Ниссан Кемикал Индастриз, Лтд.	Терапевтический агент для лечения стеноза позвоночного канала
RU2229885C2 (ru) *	1998-12-07	2004-06-10	Ниссан Кемикал Индастриз, Лтд.	Средство для лечения нарушения функции эрекции
AU2004308806B9 (en) *	2003-12-26	2010-01-28	Nissan Chemical Industries, Ltd.	Neutrophilia inhibitor
AU2009209152A1 (en) *	2008-01-29	2009-08-06	Indigo Pharmaceuticals	A method of administering a PDE3 inhibitor via titration for the treatment of peripheral arterial disease
CN113546049B (zh) *	2021-04-30	2023-03-17	贵州汉方药业有限公司	一种柔性丸剂药物黏合剂及使用该黏合剂制成的柔性丸剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4599336A (en) *	1983-08-08	1986-07-08	Hoffmann-La Roche Inc.	Derivatives of (E)-3-(4-oxo-4H-quinazolin-3-yl)-2-propenamide
EP0142057A3 (fr) *	1983-11-04	1988-03-30	F. Hoffmann-La Roche Ag	Dérivés de thiazoloquinazoline, leur préparation et compositions pharmaceutiques les contenant
US4978665A (en) *	1987-01-20	1990-12-18	Nissan Chemical Industries Ltd.	3(2H)pyridazinone, and antagonistic agent against SRS-A containing it
JPH02256668A (ja) *	1988-12-20	1990-10-17	Nissan Chem Ind Ltd	ピリダジノン誘導体
JPH07107055B2 (ja) *	1990-04-25	1995-11-15	日産化学工業株式会社	ピリダジノン誘導体

1995
- 1995-02-19 IL IL11269595A patent/IL112695A/xx not_active IP Right Cessation
- 1995-02-20 WO PCT/JP1995/000244 patent/WO1995022329A1/fr not_active Ceased
- 1995-02-20 AU AU17183/95A patent/AU1718395A/en not_active Abandoned
- 1995-02-20 DE DE69533392T patent/DE69533392T2/de not_active Expired - Lifetime
- 1995-02-20 CN CN95191744A patent/CN1084620C/zh not_active Expired - Lifetime
- 1995-02-20 DK DK95909122T patent/DK0744950T3/da active
- 1995-02-20 AT AT95909122T patent/ATE273708T1/de active
- 1995-02-20 ES ES95909122T patent/ES2222464T3/es not_active Expired - Lifetime
- 1995-02-20 US US08/687,604 patent/US5798357A/en not_active Expired - Lifetime
- 1995-02-20 CA CA002183234A patent/CA2183234C/fr not_active Expired - Lifetime
- 1995-02-20 EP EP95909122A patent/EP0744950B1/fr not_active Expired - Lifetime
- 1995-02-20 KR KR1019960704529A patent/KR100345187B1/ko not_active Expired - Lifetime
- 1995-02-21 JP JP03230095A patent/JP3858279B2/ja not_active Expired - Fee Related
- 1995-02-22 ZA ZA951470A patent/ZA951470B/xx unknown
1996
- 1996-08-20 NO NO19963463A patent/NO311490B1/no not_active IP Right Cessation
- 1996-08-21 FI FI963264A patent/FI116882B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI116882B (fi)	2006-03-31
ATE273708T1 (de)	2004-09-15
CN1141590A (zh)	1997-01-29
NO963463L (no)	1996-08-20
CA2183234C (fr)	2004-05-04
US5798357A (en)	1998-08-25
FI963264A0 (fi)	1996-08-21
ZA951470B (en)	1995-12-07
KR970701048A (ko)	1997-03-17
EP0744950B1 (fr)	2004-08-18
IL112695A0 (en)	1995-05-26
JP3858279B2 (ja)	2006-12-13
KR100345187B1 (ko)	2002-12-05
DE69533392D1 (de)	2004-09-23
ES2222464T3 (es)	2005-02-01
EP0744950A1 (fr)	1996-12-04
AU1718395A (en)	1995-09-04
DK0744950T3 (da)	2004-10-25
JPH07285869A (ja)	1995-10-31
CA2183234A1 (fr)	1995-08-24
NO311490B1 (no)	2001-12-03
DE69533392T2 (de)	2005-09-01
WO1995022329A1 (fr)	1995-08-24
FI963264A7 (fi)	1996-08-21
CN1084620C (zh)	2002-05-15

Legal Events

Date	Code	Title
1999-08-17	FF	Patent granted
2000-06-29	KB	Patent renewed
2001-06-14	KB	Patent renewed
2005-03-20	KB	Patent renewed
2009-07-27	KB	Patent renewed
2013-02-03	KB	Patent renewed
2015-09-24	EXP	Patent expired

Publication	Publication Date	Title
ZA953469B (en)	1996-01-17	New compound
MY141661A (en)	2010-05-31	17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
GEP20053600B (en)	2005-08-10	3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
NO305950B1 (no)	1999-08-23	1-amidinofenyl-pyrrolidoner, piperidinoner, azetinoner som plateaggregeringshemmere og farmasoeytiske preparater inneholdende forbindelsene
KR950702180A (ko)	1995-06-19	류코트리엔 생합성 억제제로서의 치환된 아릴알키닐-및 헤테로아릴알키닐-N-하이드록시우레아(substituted arylalkynyl-and heteroarylalkyny-N-hydroxyurea inhibi tors of leukotriene biosynthesis)본 내용은 요부공개 건이므로 전문 내용을 수록하지 않았음
NO2005019I1 (no)	2005-09-26	Metylaminolevulina, eventuelt i form av et salt, fortinnsvis metylaminolevulinat-hydroklorid
MY136173A (en)	2008-08-29	4-oxoquinoline compound and use thereof as hiv integrase inhibitor
GEP20053619B (en)	2005-09-26	Pyrazole Derivatives for Treating HIV
IN2005KO00312A (fr)	2015-08-14
WO2002007721A3 (fr)	2002-04-18	Methode
HUP0201284A2 (hu)	2002-12-28	Hatóanyagként kinazolindionszármazék kimáz inhibitort tartalmazó gyógyászati készítmények fibrózis megelőzésére vagy kezelésére
IL112695A (en)	1999-04-11	Pharmaceutical compositions containing pyridazinone derivatives
AU5844096A (en)	1996-12-18	Brain edema inhibitor
DE60318874D1 (en)	2008-03-13	Pyrazolderivate
AU7467694A (en)	1995-03-27	Pyridazinone derivatives or their salts, processes for theirproduction, and anti-shock agents containing them
AU5819394A (en)	1994-08-15	N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
PL313037A1 (en)	1996-05-27	Phenoxphenylocyclopententenylohydroxyureas
AU2003263455A1 (en)	2004-04-19	Pyrazole amides for treating hiv infections
GR3025050T3 (en)	1998-01-30	Etoposide derivatives, process for their preparation, their use as a drug and in the preparation of a drug for treating cancer.